Dioguardi, M.; Cantore, S.; Sovereto, D.; La Femina, L.; Spirito, F.; Caloro, G.A.; Caroprese, M.; Maci, M.; Scacco, S.; Lo Muzio, L.;
et al. Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis. J. Pers. Med. 2022, 12, 1436.
https://doi.org/10.3390/jpm12091436
AMA Style
Dioguardi M, Cantore S, Sovereto D, La Femina L, Spirito F, Caloro GA, Caroprese M, Maci M, Scacco S, Lo Muzio L,
et al. Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis. Journal of Personalized Medicine. 2022; 12(9):1436.
https://doi.org/10.3390/jpm12091436
Chicago/Turabian Style
Dioguardi, Mario, Stefania Cantore, Diego Sovereto, Lucia La Femina, Francesca Spirito, Giorgia Apollonia Caloro, Marino Caroprese, Marta Maci, Salvatore Scacco, Lorenzo Lo Muzio,
and et al. 2022. "Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis" Journal of Personalized Medicine 12, no. 9: 1436.
https://doi.org/10.3390/jpm12091436
APA Style
Dioguardi, M., Cantore, S., Sovereto, D., La Femina, L., Spirito, F., Caloro, G. A., Caroprese, M., Maci, M., Scacco, S., Lo Muzio, L., Di Cosola, M., Troiano, G., & Ballini, A.
(2022). Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis. Journal of Personalized Medicine, 12(9), 1436.
https://doi.org/10.3390/jpm12091436